Advertisement

Reactions Weekly

, Volume 1710, Issue 1, pp 151–151 | Cite as

Gefitinib

Various toxicities: 3 case reports
Case report

Reference

  1. Hirsch FR, et al. Long-term safety and survival with gefitinib in select patients with advanced non-small cell lung cancer: Results from the US IRESSA Clinical Access Program (ICAP). Cancer 124: 2407-2414, No. 11, 1 Jun 2018. Available from: URL: http://doi.org/10.1002/cncr.31313 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations